<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00620386</url>
  </required_header>
  <id_info>
    <org_study_id>105</org_study_id>
    <nct_id>NCT00620386</nct_id>
  </id_info>
  <brief_title>Endotracheal Intubation Using Bonfils Fibrescope Without Neuromuscular Blockade</brief_title>
  <official_title>Comparing Intubating Conditions and Hemodynamic Changes Between Macintosh Laryngoscopy and Bonfils Fibrescope During Endotracheal Intubation Without Neuromuscular Blockade</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tehran University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tehran University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We studied intubating conditions and hemodynamic changes during endotracheal intubation&#xD;
      employing either Bonfils intubating fiberscope or the conventional Macintosh laryngoscopy in&#xD;
      80 healthy patients candidates for elective surgery requiring endotracheal intubation. We&#xD;
      omitted neuromuscular blocking drugs from the induction regimen.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:&#xD;
&#xD;
      Neuromuscular blocking drugs (NMBDs) are believed to be the dominating antigens causing&#xD;
      bronchospasm and anaphylaxis during anaesthesia. Avoidance of these drugs, however, renders&#xD;
      compromised intubating conditions and higher morbidity with conventional Macintosh&#xD;
      laryngoscopy. Thus, we compared Macintosh laryngoscopy with Bonfils intubation fibrescope&#xD;
      without administering NMBDs.&#xD;
&#xD;
      METHODS:&#xD;
&#xD;
      Eighty male and female patients scheduled for elective surgery, aged 15 to 60 years, ASA&#xD;
      class II or I, non-obese, with lower risk for difficult intubation were enrolled in this&#xD;
      study. They were randomly allocated into the Bonfils group or the Macintosh group (40 each).&#xD;
      Following adequate hydration and preoxygenation, midazolam 0.05 mg kg-1 was administered,&#xD;
      followed by alfentanil 20 Âµg kg-1, lidocaine 1.5 mg kg-1, and propofol 2 mg kg-1&#xD;
      intravenously. Tracheal intubation was then carried out using Bonfils intubation fibrescope&#xD;
      (Bonfils group) or employing conventional Macintosh laryngoscopy (Macintosh group). The&#xD;
      primary outcome measure was the intubating condition, with mean arterial blood pressure and&#xD;
      heart rate as secondary outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">August 2007</completion_date>
  <primary_completion_date type="Actual">June 2007</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intubating conditions</measure>
    <time_frame>7 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>mean arterial pressure (MAP)</measure>
    <time_frame>7 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate (HR)</measure>
    <time_frame>7 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse Oxygen Saturation (SpO2)</measure>
    <time_frame>7 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Endotracheal Intubation</condition>
  <condition>Hemodynamics</condition>
  <condition>Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intubation with Bonfils intubating fiberscope</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intubation with Macintosh laryngoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bonfils</intervention_name>
    <description>Endotracheal intubation using Bonfils Intubating Fiberscope</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Macintosh</intervention_name>
    <description>Endotracheal intubation using Macintosh laryngoscopy</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiology (ASA) physical status was class I or II&#xD;
&#xD;
          -  body mass index (BMI) &lt; 30&#xD;
&#xD;
          -  ability to assume the 'sniffing' position&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  smokers&#xD;
&#xD;
          -  drug users&#xD;
&#xD;
          -  pregnant&#xD;
&#xD;
          -  expected to present difficult intubation&#xD;
&#xD;
          -  history of oesophageal reflux&#xD;
&#xD;
          -  any systemic or airway disease&#xD;
&#xD;
          -  known allergy to the protocol medications&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reza Shariat Moharari, MD</last_name>
    <role>Study Director</role>
    <affiliation>Tehran University of Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eiman Rahimi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tehran University of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sina Hospital</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <study_first_submitted>February 8, 2008</study_first_submitted>
  <study_first_submitted_qc>February 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2008</study_first_posted>
  <last_update_submitted>February 8, 2008</last_update_submitted>
  <last_update_submitted_qc>February 8, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2008</last_update_posted>
  <keyword>Intubating conditions</keyword>
  <keyword>Bonfils intubation fiberscope</keyword>
  <keyword>Macintosh laryngoscope</keyword>
  <keyword>neuromuscular blockade</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

